An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
To test the non-inferiority of duloxetine monotherapy as a treatment for the management of
diabetic peripheral neuropathic pain as compared to pregabalin treatment among patients who
have not had an adequate response to gabapentin.